RGT

0.00%

31.0¢ argent biopharma limited

Ann: Commencement of Dermatological Clinical Trials, page-34

First 34 Last

Share
Profile

Follow
37337

442 Posts.

7

27/01/17

15:26

Post #: 22174811
Share

Originally posted by serge83 ↑

FYI test crop has been harvested as per announcement December 2016.

MGC Pharmaceuticals – publicly traded on the Australian Securities Exchange – has harvested its first high-CBD cannabis test crop, setting up the company to begin production on its first research grade crop, according to a Business News report.

The test crop was grown at the MGC research laboratory in Ljubljana, Slovenia in order to evaluate growing conditions and soil nutrients. It will be used to test the company’s extraction facility. The next crop, set for the second quarter of 2017, is expected to be used for the production of medicinal raw materials and cosmetics for MGC Derma – the company’s cosmetic arm – which is on track to receive approval to market its CBD-based skincare products in the European Union, the report says.

Earlier this month, the company announced a deal to acquire Panax Pharma, a Czech-based medical cannabis company. MGC Co-founder and Managing Director Nativ Segev said that deal “will significantly strengthen” the company’s growing and research capabilities.

MGC is already backed by Perth corporate financial tycoons and has Israeli executives; the deal with highly-connected Panax, once finalized, would immediately give MGC a foothold in the European market and provide access to world-leading facilities.

Expand

Yes, harvested. But... There has been no follow-up announcement to how the harvested crop tested for CBD and THC levels, soil tests etc.. so, they can plant crop 2 but I want results from crop one.

MXC Price at posting: 4.0¢ Sentiment: None Disclosure: Not Held
2 Upvote

0 Great analysis

Reply

Top Stories

Making money: How many microcaps should be in an investor's portfolio?

Palladium's the newest geopolitical hot commodity. But ASX exposure is limited

'We're looking': Nickel-rich Indonesia sounds graphite warning to Aus producers

MIN

Movers and Shakers: Zip Co, MinRes, Kuniko, more – The week's top ASX gainers

The Altcoin Landscape (Part 1): Key alternative cryptocurrencies to watch

What each US election outcome would mean for Australian companies & investors

Week 44 Wrap: Relatively boring week ahead of US election; HotCopper's most watched; Oz inflation at 3.5%

MKT

The ASX can overlook its Telecomm small-caps. Here’s one diversified brand with an international footprint

Bitcoin hits fresh record as instos pile into BTC ETFs – and Trump helps, too

Aussie inflation seemingly hit a 3 year low. So why's the ASX200 red?

There are more pages in this discussion • 5 more messages in this thread...

First 34 Last

Add RGT (ASX) to my watchlist

(20min delay)
Last 31.0¢		Change 0.000(0.00%)		Mkt cap ! $16.82M

Open	High	Low	Value	Volume
31.0¢	31.0¢	31.0¢	$604	1.948K

Buyers (Bids)

No.	Vol.	Price($)
1	3921	25.5¢

Sellers (Offers)

Price($)	Vol.	No.
30.5¢	2073	2

View Market Depth

No.	Vol.	Price($)
1	3921	0.255
3	14904	0.250
1	3988	0.245
1	2200	0.230
1	16950	0.210

Price($)	Vol.	No.
0.305	2073	2
0.310	50	1
0.320	50	1
0.330	105	1
0.395	5754	1

Last trade - 12.55pm 01/11/2024 (20 minute delay)

RGT (ASX) Chart

Ann: Commencement of Dermatological Clinical Trials, page-34

Making money: How many microcaps should be in an investor's portfolio?

Palladium's the newest geopolitical hot commodity. But ASX exposure is limited

'We're looking': Nickel-rich Indonesia sounds graphite warning to Aus producers

Movers and Shakers: Zip Co, MinRes, Kuniko, more – The week's top ASX gainers

The Altcoin Landscape (Part 1): Key alternative cryptocurrencies to watch

What each US election outcome would mean for Australian companies & investors

Week 44 Wrap: Relatively boring week ahead of US election; HotCopper's most watched; Oz inflation at 3.5%

The ASX can overlook its Telecomm small-caps. Here’s one diversified brand with an international footprint

Bitcoin hits fresh record as instos pile into BTC ETFs – and Trump helps, too

Aussie inflation seemingly hit a 3 year low. So why's the ASX200 red?

Featured News

Buyers (Bids)

Sellers (Offers)

Featured News

Ann: Commencement of Dermatological Clinical Trials, page-34

Top Stories

Making money: How many microcaps should be in an investor's portfolio?

Palladium's the newest geopolitical hot commodity. But ASX exposure is limited

'We're looking': Nickel-rich Indonesia sounds graphite warning to Aus producers

Movers and Shakers: Zip Co, MinRes, Kuniko, more – The week's top ASX gainers

The Altcoin Landscape (Part 1): Key alternative cryptocurrencies to watch

What each US election outcome would mean for Australian companies & investors

Week 44 Wrap: Relatively boring week ahead of US election; HotCopper's most watched; Oz inflation at 3.5%

The ASX can overlook its Telecomm small-caps. Here’s one diversified brand with an international footprint

Bitcoin hits fresh record as instos pile into BTC ETFs – and Trump helps, too

Aussie inflation seemingly hit a 3 year low. So why's the ASX200 red?

Featured News

Buyers (Bids)

Sellers (Offers)

Featured News